MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 8 | 0.0 |
Animals | 26 | 0.0 |
Binding Sites | 3 | 0.0 |
Calcium/metabolism | 11 | 0.0 |
Cell Line | 23 | 0.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
Humans | 45 | 0.0 |
Ion Channels/*chemistry/genetics/*metabolism | 2 | 66.0 |
Molecular Sequence Data | 10 | 0.0 |
Mutation | 7 | 0.0 |
Protein Binding | 6 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Rats | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Signal Transduction | 2 | 0.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
Aged | 2 | 0.0 |
Female | 7 | 0.0 |
Electrophysiology | 4 | 0.0 |
Gene Expression | 2 | 0.0 |
Ion Channels/metabolism | 3 | 11.0 |
Mice | 6 | 0.0 |
Phospholipase C/metabolism | 8 | 2.0 |
Genotype | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 30 | 0.0 |
Calcium Channels/chemistry/genetics/*metabolism | 2 | 40.0 |
Calcium Signaling/physiology | 2 | 5.0 |
Male | 5 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Adult | 3 | 0.0 |
Cell Cycle | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Ion Channels/*genetics | 2 | 4.0 |
Middle Aged | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Calcium Signaling/*physiology | 5 | 10.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Ion Channels/genetics/*metabolism | 6 | 27.0 |
Kidney/cytology | 2 | 1.0 |
Membrane Proteins/genetics/*metabolism | 2 | 0.0 |
Thapsigargin/pharmacology | 4 | 3.0 |
Transfection | 13 | 0.0 |
Calcium/*metabolism | 12 | 1.0 |
Animals, Genetically Modified | 2 | 0.0 |
B-Lymphocytes/metabolism | 2 | 1.0 |
Cells, Cultured | 10 | 0.0 |
Chickens | 6 | 0.0 |
Estrenes/pharmacology | 2 | 5.0 |
Isoenzymes/metabolism | 3 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Pyrrolidinones/pharmacology | 2 | 3.0 |
Receptors, Antigen, B-Cell/metabolism | 2 | 4.0 |
Time Factors | 7 | 0.0 |
Calcium Channels/genetics/*metabolism | 3 | 15.0 |
Ion Channels/genetics/metabolism | 3 | 33.0 |
Receptors, Cytoplasmic and Nuclear/metabolism | 4 | 3.0 |
Calcium Channels/*metabolism | 6 | 13.0 |
Cations | 3 | 3.0 |
Cell Membrane/metabolism | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Immunoblotting | 4 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 4 | 2.0 |
Carbachol/pharmacology | 2 | 2.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Base Sequence | 4 | 0.0 |
Blotting, Western | 3 | 0.0 |
DNA Primers | 4 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Ion Channel Gating | 2 | 2.0 |
Ion Channels/*metabolism | 3 | 7.0 |
Manganese/metabolism | 3 | 9.0 |
Patch-Clamp Techniques | 2 | 0.0 |
Ion Channels/chemistry/genetics/*metabolism | 2 | 28.0 |
Phospholipase C/pharmacology | 2 | 5.0 |
Calcium Signaling | 2 | 2.0 |
Diacylglycerol Kinase/antagonists & inhibitors | 2 | 66.0 |
Diglycerides/pharmacology | 3 | 8.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
*Calcium Signaling | 3 | 7.0 |
Inositol 1,4,5-Trisphosphate/pharmacology | 2 | 25.0 |
Calcium Channels/physiology | 2 | 10.0 |
Cations/metabolism | 2 | 9.0 |
Pregnancy | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Jurkat Cells | 3 | 0.0 |
*Membrane Proteins | 4 | 0.0 |
Comparative Study | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
*Ion Channels | 2 | 6.0 |
Lymphocyte Activation | 2 | 0.0 |
Calcium Channels/*genetics/*metabolism | 2 | 22.0 |
*Gene Expression Profiling | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
*Cation Transport Proteins | 2 | 0.0 |
Receptor, Muscarinic M5 | 2 | 100.0 |
Calcium Channels/drug effects/*physiology | 2 | 28.0 |
